Trending topics and news in HCT and Cellular Therapy

Protecting Patients Through Science-Driven Leadership

In this month's President’s Message, Dr. David Porter shares his perspective on the recent dismissal of the CDC’s vaccine advisory committee—and why it matters. He breaks down the potential risks to public health and immunization policy, especially for patients in transplantation and cellular therapy, and underscores the importance of science guiding our decisions. Dr. Porter also spotlights ASTCT’s ongoing investments in education, training, and exciting events on the horizon, all part of our mission to support the next generation of innovators in the field.

David Porter, MD